InVivoMAb anti-human CD8alpha
BE0004-2
ApplicationsOther Application
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human CD8alpha
- Delivery Days Customer7
- ApplicationsOther Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDOKT-8
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Chijioke O, Marcenaro E, Moretta A, et al. Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components. J Infect Dis. 2015,212(5):803-7. doi: 10.1093/infdis/jiv114Read this paper
- Chijioke O, Müller A, Feederle R, et al. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep. 2013,5(6):1489-98. doi: 10.1016/j.celrep.2013.11.041Read this paper
- Billerbeck E, Horwitz JA, Labitt RN, et al. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J Immunol. 2013,191(4):1753-64. doi: 10.4049/jimmunol.1201518Read this paper
